These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

Wall Street is pointing sharply lower Monday following President Donald Trump’s orders to impose steep tariffs on the biggest U.S. trading partners: Mexico, Canada and China.

Older Black men account for a growing share of Milwaukee drug deaths as fentanyl creeps into cocaine supplies, catching a ...

Trump’s orders say the tariffs are a consequence of illegal immigration and drug smuggling. Not everyone will agree with his ...

Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a peak the stock set in November, ...

Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...

The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...